SABBY MANAGEMENT, LLC

Position in REVB — Revelation Biosciences, Inc.

CIK 1535610 MIAMI BEACH, FL

Position in REVB

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$216,899

+$97,581 QoQ

Shares Held

210,582

+111.8% QoQ

Ownership

5.29%

of shares outstanding

% of Portfolio

1.88%

of 13F equity value

Holder Rank

of 12 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

SABBY MANAGEMENT, LLC holds $1,817,490 across 4 Biotechnology names. REVB ranks #4 (11.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRVO	CervoMed Inc.	248,880	$771,528
2	TPST	Tempest Therapeutics, Inc.	511,286	$567,527
3	BCTX	BriaCell Therapeutics Corp.	391,906	$261,536
4	REVB	Revelation Biosciences, Inc. This page	210,582	$216,899

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$216,899	210,582	+111.8%	Shares	Defined	2026-08-14
2026-03-31	$119,318	99,432	-83.6%	Shares	Defined	2026-05-15
2025-12-31	$484,561	605,702	+192.5%	Shares	Defined	2026-02-17
2025-09-30	$294,012	207,051	+214.7%	Shares	Defined	2025-11-14
2025-06-30	$49,341	65,789	+55.8%	Shares	Defined	2025-08-14
2024-09-30	$35,976	42,226	-89.5%	Shares	Defined	2024-11-14
2023-12-31	$202,019	403,233	0.0%	Shares	Defined	2024-02-14
2023-09-30	$277,827	403,233	+14.2%	Shares	Defined	2023-11-14
2023-06-30	$332,039	353,233	+95.8%	Shares	Defined	2023-08-14
2023-03-31	$234,560	180,431	—	Shares	Defined	2023-05-15
No filing history on record for this holder in this stock.